$4.06 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About SomaLogic

SomaLogic, Inc., formerly CM Life Sciences II Inc., is a protein biomarker discovery and clinical diagnostics company. The Company develops slow-off rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Company's products include SomaScan and SomaSignal, which are available as laboratory developed tests (LDTs) used in obtaining proteomics information from patients, and monitoring patients' physiological states. The Company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Biomarker discoveries from SomaScan provides diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis and wellness.

Stock Analysis

last close $4.25
1-mo return -16.3%
3-mo return -20.6%
avg daily vol. 1.74M
52-week high 14.72
52-week low 3.65
market cap. $808M
forward pe -
annual div. -
roe -28.1%
ltg forecast -
dividend yield -
annual rev. $86M
inst own. 68.6%

Subscribe now for daily local and international financial news